Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.08%61.590.0%$953.82m
GILDGilead Sciences, Inc. -1.14%76.061.0%$768.72m
AMGNAmgen, Inc. 8.17%255.121.3%$748.85m
REGNRegeneron Pharmaceuticals, Inc. -2.32%609.172.5%$678.56m
NVAXNovavax, Inc. -4.38%79.70102.0%$606.94m
BIIBBiogen, Inc. -1.04%264.771.6%$543.38m
VRTXVertex Pharmaceuticals, Inc. -1.39%286.281.9%$524.18m
ILMNIllumina, Inc. -0.49%368.553.5%$308.59m
ALXNAlexion Pharmaceuticals, Inc. 0.13%112.392.0%$229.11m
BMRNBioMarin Pharmaceutical, Inc. 2.03%125.844.3%$214.73m
SGENSeattle Genetics, Inc. -1.41%167.526.1%$201.85m
SRNESorrento Therapeutics, Inc. 10.35%6.931.8%$186.93m
SRPTSarepta Therapeutics, Inc. 3.33%165.6813.9%$168.66m
INCYIncyte Corp. -1.27%102.652.5%$160.00m
IMMUImmunomedics, Inc. 4.15%36.9111.0%$154.32m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.